Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen
Keynote Presentation (In-Person)
Jacqueline Tuppen, Dementia UK, United Kingdom

In the UK an Admiral Nurse survey in 2023, found that carers needed help and support with a variety of issues that included coordinating care, communicating with the variety of different specialists and support networks plus accessing information to help them understand the condi [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua
Keynote Presentation (In-Person)
Jun Hua, Johns Hopkins University , United States

The circulation of cerebrospinal fluid (CSF) plays a critical role in waste clearance and immune surveillance throughout the central nervous system (CNS). Dysfunction of this system has been associated with numerous deleterious effects and is thought to play a significant role in [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu
Keynote Presentation (Virtual)
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China

Background Autism spectrum disorders (ASD) are a series of neurodevelopmental disorders characterized by social disorders, rigid behaviors and narrow interests.The World Health Organization (WHO) estimates that the prevalence of ASD has been increasing over the past 50 years. Wit [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Frank Balikoowa
Oral Presentation (In-Person)
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda

Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive and functional abilities. The Apolipoprotein E (APOE) gene, particularly its ε2, ε3, and ε4 alleles, plays a crucial role in lipi [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Christopher Hubler
Oral Presentation (In-Person)
Christopher Hubler, Emergent Neural Systems Institute for Research, United States

Background: Network hyperexcitability and subclinical epileptiform activity occur in a subset of patients with Alzheimer disease (AD) and have emerged as candidate therapeutic targets. Low-dose levetiracetam (LEV) has not demonstrated overall cognitive benefit in AD, although ex [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu
Oral Presentation (Virtual)
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China

Objective: To investigate the effect of and Acupuncture on brain plasticity and motor development in children with cerebral palsy. Investigate effect on mechanism of apoptosis of brain nerve cells, regulating the expression of neurotrophic factors, promoting the remodeling of ne [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Abhishek Bansal
Oral Presentation (Virtual)
Abhishek Bansal, New Era Consultancy Services, India

Alzheimer's disease is a progressive neurodegenerative disorder associated with cognitive decline, memory impairment, synaptic dysfunction, and disturbances in neuronal communication. Although amyloid-beta accumulation, tau pathology, neuroinflammation, and neuronal degenerat [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Mohamed Abdilahi Duale
Poster Presentation (In-Person)
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia

Objective: In Somaliland, dementia is one of the leading causes of disability among older adults, and healthcare professionals play a vital role in dementia care. However, no study has been done on their perspectives and understanding of dementia care. The purpose of the current [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Yun Ju Hsieh
Poster Presentation (In-Person)
Yun Ju Hsieh, Taipei City Hospital, Taiwan

Aims: Depressive symptoms are frequent neuropsychiatric manifestations in older adults with cognitive impairment and dementia. This study aimed to examine the association between depressive symptom severity and dementia severity in a real-world memory clinic cohort. We also eval [....] » Read More

Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Simona Opris
Poster Presentation (Virtual)
Simona Opris, Ana Aslan National Institute of Gerontology and Geriatrics, Romania

Early identification of risk factors for cognitive impairment is essential for prevention and therapeutic management. Normal aging comes with some cognitive decline, but when these changes become significant they may indicate the existence of a cognitive disorder. Systemic inflam [....] » Read More

Scientific Programs coming soon..

Scientific Programs coming soon..

Whatsapp